As 2017 comes to a close, we'd like to thank you for subscribing to the Cancer Currents blog. We hope you find it to be a useful resource for the latest news on cancer research, NCI programs and initiatives, Food and Drug Administration approvals, and more.
We published nearly 130 posts on Cancer Currents this year. Some were of particular interest, judging from the number of clicks they received.
Thanks for reading Cancer Currents, and happy holidays from our editorial team.